Levaquin and Pulmonary haemorrhage - a phase IV clinical study of FDA data

Summary:

Pulmonary haemorrhage is reported as a side effect among people who take Levaquin (levofloxacin), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Lasix, and have Pain.

The phase IV clinical study analyzes which people have Pulmonary haemorrhage when taking Levaquin. It is created by eHealthMe based on reports of 54,998 people who have side effects when taking Levaquin from the FDA, and is updated regularly.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

What is Pulmonary haemorrhage?

Pulmonary haemorrhage (acute bleeding from the lung) is found to be associated with 776 drugs and 935 conditions by eHealthMe. Check the latest studies of Pulmonary haemorrhage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

54,998 people reported to have side effects when taking Levaquin.
Among them, 65 people (0.12%) have Pulmonary haemorrhage.

Could Levaquin cause Pulmonary haemorrhage?

Among these 65 people:

How long have people been on Levaquin when they have Pulmonary haemorrhage? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pulmonary haemorrhage when taking Levaquin? *

  • female: 45.31 %
  • male: 54.69 %

What is the age of people who have Pulmonary haemorrhage when taking Levaquin? *

  • 0-1: 0.0 %
  • 2-9: 3.64 %
  • 10-19: 1.82 %
  • 20-29: 7.27 %
  • 30-39: 1.82 %
  • 40-49: 18.18 %
  • 50-59: 34.55 %
  • 60+: 32.73 %

What are other drugs people take besides Levaquin? *

  1. Lasix: 18 people, 27.69%
  2. Synthroid: 17 people, 26.15%
  3. Prednisone: 14 people, 21.54%
  4. Velcade: 13 people, 20.00%
  5. Pepcid: 13 people, 20.00%
  6. Allopurinol: 12 people, 18.46%
  7. Thalidomide: 12 people, 18.46%
  8. Tylenol: 12 people, 18.46%
  9. Amicar: 12 people, 18.46%
  10. Warfarin Sodium: 11 people, 16.92%

What are other side effects people have besides Pulmonary haemorrhage? *

  1. Fever: 22 people, 33.85%
  2. Thrombocytopenia (decrease of platelets in blood): 18 people, 27.69%
  3. Coughing Up Blood: 17 people, 26.15%
  4. Hypotension (abnormally low blood pressure): 17 people, 26.15%
  5. Anaemia (lack of blood): 16 people, 24.62%
  6. Rashes (redness): 15 people, 23.08%
  7. Oedema Peripheral (superficial swelling): 14 people, 21.54%
  8. Enlarged Heart: 14 people, 21.54%
  9. Heart Attack: 14 people, 21.54%
  10. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 13 people, 20.00%

What are the existing conditions these people have? *

  1. Pain: 14 people, 21.54%
  2. Multiple Myeloma (cancer of the plasma cells): 13 people, 20.00%
  3. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 10 people, 15.38%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 10.77%
  5. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 9.23%
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 7.69%
  7. High Blood Pressure: 4 people, 6.15%
  8. Itching: 4 people, 6.15%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.15%
  10. Respiratory Tract Infection: 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Levaquin and have Pulmonary haemorrhage?

- Check whether Pulmonary haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levaquin:

Pulmonary haemorrhage treatments and more:

How severe was Pulmonary haemorrhage and when was it recovered:

Expand to all the drugs that have ingredients of levofloxacin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary haemorrhage:

Browse all the conditions that are associated with Pulmonary haemorrhage:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levofloxacin (the active ingredients of Levaquin) and Levaquin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: